Nutex Health, Inc. (NUTX) — Financial statements
Income statement, balance sheet, and cash flow for Nutex Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 875↑82.4% | 480↑93.8% | 248↑12.9% | 219↓33.9% | 332 | |
| Cost of Revenue | 431↑51.9% | 284↑33.3% | 213↑4.4% | 204↑33.9% | 152 | |
| Gross Profit | 444↑126.4% | 196↑464.4% | 35↑125.5% | 15↓91.4% | 179 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.29 | |
| General & Administrative Expenses | 169↑188.0% | 59↑76.2% | 33↑66.1% | 20↑266.1% | 5 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 3 | 0.00 | 0.00 | |
| SG&A Expenses | 169↑188.0% | 59↑62.4% | 36↑80.3% | 20↑266.1% | 5 | |
| Other Expenses | 0.00↓100.0% | 7↓76.8% | 30↓92.4% | 402↑12202.4% | 3 | |
| Operating Expenses | 169↑156.9% | 66↓1.4% | 67↓84.2% | 422↑4580.8% | 9 | |
| Total Costs & Expenses | 600↑71.7% | 349↑25.0% | 279↓55.4% | 626↑288.1% | 161 | |
| Operating Results | ||||||
| Operating Income | 276↑111.0% | 131↑511.1% | -32↑92.2% | -407↓338.8% | 170 | |
| Depreciation & Amortization | 21↑8.2% | 19↑7.8% | 18↑34.0% | 13↑69.2% | 8 | |
| EBITDA | 288↑93.4% | 149↑1119.5% | -15↑96.3% | -394↓314.8% | 183 | |
| EBIT | 267↑105.9% | 130↑503.1% | -32↑92.1% | -407↓331.8% | 176 | |
| Interest & Other Income | ||||||
| Net Interest Income | -22↓11.5% | -20↓22.1% | -16↓30.6% | -12↓101.6% | -6 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 22↑11.5% | 20↑22.1% | 16↑30.6% | 12↑101.6% | 6 | |
| Non-Operating Income | 9↑816.8% | 0.94↑135.5% | 0.40↓28.6% | 0.56↑110.3% | -5 | |
| Other Income / Expenses | -31↓47.8% | -21↓24.9% | -17↓28.1% | -13↓1586.2% | -0.77 | |
| Income Before Tax | 245↑123.0% | 110↑326.3% | -48↑88.4% | -420↓347.6% | 169 | |
| Income Tax Expense | 64↑345.0% | 14↑385.7% | -5↓138.7% | 13↑1255.5% | 0.97 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 180↑89.3% | 95↑319.4% | -43↑90.0% | -433↓356.8% | 169 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 71↑35.7% | 52↑214.0% | -46↑89.2% | -425↓420.4% | 133 | |
| Bottom-Line Net Income | 71↑33.0% | 53↑216.3% | -46↑89.2% | -425↓420.4% | 133 | |
| EPS (Basic) | 11.13↑8.8% | 10.23↑198.5% | -10.39↑89.7% | -100.50↓399.6% | 33.55 | |
| EPS (Diluted) | 10.48↑7.9% | 9.71↑193.5% | -10.39↑89.6% | -100.36↓399.1% | 33.55 | |
| Weighted Average Shares | 6↑24.7% | 5↑15.7% | 4↑4.3% | 4↑5.2% | 4 | |
| Weighted Average Diluted Shares | 7↑32.5% | 5↑15.7% | 4↑4.2% | 4↑7.1% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.